Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

An Unusual FDA Panel on Antidepressant Use During Pregnancy Elevated Skeptics of the Drugs

UNITED STATES, JUL 24 – FDA panel debated SSRI risks to fetal development versus dangers of untreated depression, with CDC reporting mental health issues as leading cause of pregnancy-related deaths.

Summary by STAT
Makary is recruiting researchers to weigh in on hormone therapy and SSRIs. The panels seem to have a bias, and the FDA’s goal is unclear.

3 Articles

STATSTAT
Center

An unusual FDA panel on antidepressant use during pregnancy elevated skeptics of the drugs

Makary is recruiting researchers to weigh in on hormone therapy and SSRIs. The panels seem to have a bias, and the FDA’s goal is unclear.

·Boston, United States
Read Full Article
Legal ReaderLegal Reader
Left

FDA Panel Questions SSRI Use in Pregnancy - Legal Reader

FDA Panel Questions SSRI Use in Pregnancy

Read Full Article
MedscapeMedscape

FDA Panel Casts Doubt on Safety of SSRI Use in Pregnancy

At a recent FDA panel on SSRIs in pregnancy, the chair suggested rising antidepressant use may be contributing to — not easing — the nation’s depression rates.

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Legal Reader broke the news in on Thursday, July 24, 2025.
Sources are mostly out of (0)

Similar News Topics

Medical icon

Medical

United States icon

United States

News
For You
SearchBlindspotLocal